EUVIMEDEUVIMED entdecken
Open Access

STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway

Lei Wang, Xianjin Xie

Oncology Research · 2025

DOI: 10.32604/or.2024.048562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Lei Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Jen Ching Memorial Hospital, Suzhou, 215300, China. Hauptthemen laut MEDLINE: Glycolysis, Adenocarcinoma of Lung, E2F1 Transcription Factor, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate SCL/TAL 1 interrupting locus (STIL)'s role and prognostic significance in lung adenocarcinoma (LUAD) progression, we examined STIL and E2 promoter binding factor 1 (E2F1) expression and their impacts on LUAD prognosis using Gene Expression Profiling Interactive Analysis (GEPIA).

Methods

Functional assays including CCK-8, wound-healing, 5-ethynyl-2-deoxyuridine (EdU), Transwell assays, and flow cytometry, elucidated STIL and E2F1's effects on cell viability, proliferation, apoptosis, and migration. Gene set enrichment analysis (GSEA) identified potential pathways, while metabolic assays assessed glucose metabolism.

Results

Our findings reveal that STIL and E2F1 are overexpressed in LUAD, correlating with adverse outcomes. It enhances cell proliferation, migration, and invasion, and suppresses apoptosis, activating downstream of E2F1. Silencing E2F1 reversed the promotion effect of the STIL overexpression on cell viability and invasiveness. Importantly, STIL modulates glycolysis, influencing glucose consumption, lactate production, and energy balance in LUAD cells.

Conclusion

Our model, incorporating STIL, age, and disease stage, robustly predicts patient prognosis, underscored STIL's pivotal role in LUAD pathogenesis through metabolic reprogramming. This comprehensive approach not only confirms STIL's prognostic value but also highlights its potential as a therapeutic target in LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisAdenocarcinoma of LungE2F1 Transcription FactorLung NeoplasmsCell ProliferationHumansPrognosisCell Line, TumorApoptosisCell MovementGene Expression Regulation, NeoplasticBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

E2 promoter binding factor 1GlycolysisLung adenocarcinomaSCL/TAL1 interrupting locus (STIL)

Substanzen

E2F1 Transcription FactorBasic Helix-Loop-Helix ProteinsE2F1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Jen Ching Memorial Hospital, Suzhou, 215300, China.
  • Department of Respiratory Medicine, Shandong Provincial Third Hospital, Jinan, 250010, China.

Zitieren

APA

Wang, L., & Xie, X. (2025). STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway. Oncology Research. https://doi.org/10.32604/or.2024.048562

Vancouver

Wang L, Xie X. STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway. Oncology Research. 2025. doi:10.32604/or.2024.048562

BibTeX
@article{Wang2025,
  author = {Wang, Lei and Xie, Xianjin},
  title = {STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.048562}
}
Kostenlos starten →